| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $4.01M | - | |
| COO | 986.4K | $39.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 10,057 | $1.86 | $18,685.91 | -43.0% | |
| Jan 12, 2023 | Bertrand William C Jr | Chief Operating Officer | Sell | 8,816 | $1.72 | $15,196.89 | -38.0% | |
| Jan 12, 2023 | Lunger John | Chief Patient Supply Officer | Sell | 8,816 | $1.72 | $15,196.89 | -38.0% | |
| Jan 12, 2023 | Norry Elliot | Chief Medical Officer | Sell | 11,292 | $1.72 | $19,420.95 | -38.0% | |
| Jan 12, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 31,805 | $1.72 | $54,791.44 | -43.0% | |
| Jan 4, 2023 | Bertrand William C Jr | Chief Operating Officer | Sell | 3,584 | $1.69 | $6,071.30 | -38.3% | |
| Jan 4, 2023 | Lunger John | Chief Patient Supply Officer | Sell | 1,100 | $1.69 | $1,863.40 | -38.9% | |
| Jan 4, 2023 | Norry Elliot | Chief Medical Officer | Sell | 876 | $1.69 | $1,483.94 | -39.2% | |
| Jan 4, 2023 | Rawcliffe Adrian | Chief Executive Officer | Sell | 5,073 | $1.69 | $8,593.66 | -43.3% | |
| Sep 1, 2022 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,536 | $1.97 | $4,993.13 | -43.3% |